Published guidance, NICE advice and quality standards

Showing 561 to 570 of 757

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Panobinostat for treating multiple myeloma after at least 2 previous treatments	TA380	27 January 2016	27 January 2016
Eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal)	TA382	27 January 2016	27 January 2016
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	26 January 2016	26 January 2016
Guidance on the use of imatinib for chronic myeloid leukaemia	TA70	22 October 2003	21 January 2016
Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears	TA369	16 December 2015	16 December 2015
Bortezomib for previously untreated mantle cell lymphoma	TA370	16 December 2015	16 December 2015
Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis	TA373	16 December 2015	16 December 2015
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy	TA374	16 December 2015	16 December 2015
Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C	TA365	25 November 2015	25 November 2015
Vortioxetine for treating major depressive episodes	TA367	25 November 2015	25 November 2015